Published 30 April 2009, doi:10.1136/bmj.b1649
Cite this as: BMJ 2009;338:b1649

Research

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study

Evan Wood, research scientist1, Thomas Kerr, research scientist1, Brandon D L Marshall, PhD candidate2, Kathy Li, senior statistician1, Ruth Zhang, statistician1, Robert S Hogg, director, HIV/AIDS drug treatment program1, P Richard Harrigan, director, research laboratories1, Julio S G Montaner, head3

1 British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 2 School of Population and Public Health, University of British Columbia, Vancouver, 3 Division of AIDS, Department of Medicine, University of British Columbia, Vancouver

Correspondence to: E Wood uhri-ew{at}cfenet.ubc.ca

Objective To examine the relation between plasma HIV-1 RNA concentrations in the community and HIV incidence among injecting drug users.

Design Prospective cohort study.

Setting Inner city community in Vancouver, Canada.

Participants Injecting drug users, with and without HIV, followed up every six months between 1 May 1996 and 30 June 2007.

Main outcome measures Estimated community plasma HIV-1 RNA in the six months before each HIV negative participant’s follow-up visit. Associated HIV incidence.

Results Among 622 injecting drug users with HIV, 12 435 measurements of plasma HIV-1 RNA were obtained. Among 1429 injecting drug users without HIV, there were 155 HIV seroconversions, resulting in an incidence density of 2.49 (95% confidence interval 2.09 to 2.88) per 100 person years. In a Cox model that adjusted for unsafe sexual behaviours and sharing used syringes, the estimated community plasma HIV-1 RNA concentration remained independently associated with the time to HIV seroconversion (hazard ratio 3.32 (1.82 to 6.08, P<0.001), per log10 increase). When the follow-up period was limited to observations after 1 January 1988 (when the median plasma HIV RNA concentration was <20 000 copies/ml), the median viral load was no longer statistically associated with HIV incidence (1.70 (0.79 to 3.67, P=0.175), per log10 increase).

Conclusions A longitudinal measure of community plasma HIV-1 RNA concentration was correlated with the community HIV incidence rate and predicted HIV incidence independent of unsafe sexual behaviours and sharing used syringes. If these findings are confirmed, they could help to inform both HIV prevention and treatment interventions.

© Wood et al 2009
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Fauci, A. S., Folkers, G. K. (2009). Investing To Meet The Scientific Challenges Of HIV/AIDS. Health Aff (Millwood) 28: 1629-1641 [Abstract] [Full text]  
  • DeBeck, K., Kerr, T., Li, K., Fischer, B., Buxton, J., Montaner, J., Wood, E. (2009). Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. CMAJ 181: 585-589 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Typo?
John T. Brooks
bmj.com, 23 May 2009 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ